Literature DB >> 1392324

The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.

M Noguchi1, N Ohta, N Koyasaki, T Taniya, I Miyazaki, Y Mizukami.   

Abstract

We evaluated the relationship between the regional lymph node metastases and the DNA ploidy status in 207 patients with invasive breast cancer, as well as their prognostic values in estimating the prognosis of breast cancer. A significantly higher incidence of aneuploidy was found in patients with a large T3 or T4 tumor, a positive axillary lymph node status, more than 4 positive axillary lymph nodes or positive internal mammary lymph nodes. In a univariate study, the overall survival was significantly correlated with tumor size, axillary lymph node status, axillary and internal mammary lymph node metastases, and DNA ploidy status. In the multivariate analysis, however, only axillary and internal mammary lymph node metastases were recognized as important independent prognostic factors on survival. In this series, the DNA ploidy status did not appear to be an independent prognostic factor either in the entire series or in negative axillary node patients, since it was closely correlated with the axillary or internal mammary lymph node metastases, and the axillary node negative patients had an extremely favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392324     DOI: 10.1007/bf00308825

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  39 in total

1.  Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

Authors:  A M Uyterlinde; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

2.  Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.

Authors:  E G Mansour; R Gray; A H Shatila; C K Osborne; D C Tormey; K W Gilchrist; M R Cooper; G Falkson
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

3.  Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?

Authors:  S Keyhani-Rofagha; R V O'Toole; W B Farrar; B Sickle-Santanello; J DeCenzo; D Young
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

4.  The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients.

Authors:  J C van der Linden; J Lindeman; J P Baak; C J Meijer; C J Herman
Journal:  Cytometry       Date:  1989-01

5.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

6.  Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy.

Authors:  D Rosner; W W Lane
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

7.  Prognostic significance of the DNA content of human breast cancer.

Authors:  C S Dowle; A Owainati; A Robins; K Burns; I O Ellis; C W Elston; R W Blamey
Journal:  Br J Surg       Date:  1987-02       Impact factor: 6.939

8.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

9.  DNA flow cytometry in primary breast carcinoma.

Authors:  S D Fosså; E Thorud; M C Shoaib; E O Pettersen; J Høie; O S Knudsen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-11

10.  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

Authors:  T E Kute; H B Muss; D Anderson; K Crumb; B Miller; D Burns; L A Dube
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.